JP Morgan Maintains Overweight on RH, Lowers Price Target to $338
Portfolio Pulse from Benzinga Newsdesk
JP Morgan analyst Christopher Horvers maintains an Overweight rating on RH but lowers the price target from $345 to $338.
September 16, 2024 | 3:38 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
JP Morgan's analyst Christopher Horvers maintains an Overweight rating on RH but reduces the price target from $345 to $338, indicating a slightly less optimistic outlook.
The Overweight rating suggests continued confidence in RH's performance, but the lowered price target indicates a slight reduction in expected upside. This mixed signal may result in a neutral short-term impact on RH's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100